BioBac Subchapter
Registration
Programm
Onena Medicines – Dr. Neethan Lobo (CEO) - Basel/San Sebastian
Innovative company in the oncology space. Onena’s antibodies are specifically
designed to block the activity of DSIP proteins; DSIPs are powerful secreted
proteins by resistant cancer cells that allow them to maintain their growth.
Inura Medical – Vanja Ivancevic (CEO) - Liestal
Patient-friendly and local treatment method for overactive bladder (OAB) in
women. Inura is developing a novel drug delivery approach by creating a
urethral ovulum that can be used for OAB treatment and is expected to have
fewer side effects.
Flowbone - Régis Gauderon (CEO) - Vaud
Revolutionary biomaterial for the minimal-invasive augmentation of fragile
bones. The company follows a new treatment approach that allows fragilized
bones to augment and repair themselves without impeding bone mechanics or
blood flow within the bone.
VISCHER is supporting BioValley for this event.